The neurodevelopmental model of schizophrenia: update 2005
The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Abstract
Neurodevelopmental models of schizophrenia that identify longitudinal precursors of illness have been of great heuristic importance focusing most etiologic research over the past two decades. These models have varied considerably with respect to specificity and timing of hypothesized genetic and environmental 'hits', but have largely focused on insults to prenatal brain development. With heritability around 80%, nongenetic factors impairing development must also be part of the model, and any model must also account for the wide range of age of onset. In recent years, longitudinal brain imaging studies of both early and adult (to distinguish from late ie elderly) onset populations indicate that progressive brain changes are more dynamic than previously thought, with gray matter volume loss particularly striking in adolescence and appearing to be an exaggeration of the normal developmental pattern. This supports an extended time period of abnormal neurodevelopment in schizophrenia in addition to earlier 'lesions'. Many subtle cognitive, motor, and behavioral deviations are seen years before illness onset, and these are more prominent in early onset cases. Moreover, schizophrenia susceptibility genes and chromosomal abnormalities, particularly as examined for early onset populations (ie GAD1, 22q11DS), are associated with premorbid neurodevelopmental abnormalities. Several candidate genes for schizophrenia (eg dysbindin) are associated with lower cognitive abilities in both schizophrenic and other pediatric populations more generally. Postmortem human brain and developmental animal studies document multiple and diverse effects of developmental genes (including schizophrenia susceptibility genes), at sequential stages of brain development. These may underlie the broad array of premorbid cognitive and behavioral abnormalities seen in schizophrenia, and neurodevelopmental disorders more generally. Increased specificity for the most relevant environmental risk factors such as exposure to prenatal infection, and their interaction with susceptibility genes and/or action through phase-specific altered gene expression now both strengthen and modify the neurodevelopmental theory of schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, the association of pervasive developmental disorders (PDD) and psychosis is in consonance with the finding, from the NIMH very early-onset SZ sample, of a history of PDD (as per DSM-III) in roughly a third of the patients with SZ. 55”
From Developmental Differences Between Schizophrenia and Bipolar Disorder (2017) · cites this paper as [55]
Citations
Cites
Epigenetic programming by maternal behavior
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Large-scale copy number polymorphism in the human genome
Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., Månér, S., Massa, H., Walker, M., Chi, M., et al. (2004) · Science · doi:10.1126/science.1098918 · Cited by 2,557
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W.-L., Chen, C., Zhai, Y., et al. (1998) · Nature Genetics · doi:10.1038/2524 · Cited by 2,240
Kim-Cohen, J., Caspi, A., Moffitt, T. E., Harrington, H., Milne, B. J., & Poulton, R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.709 · Cited by 2,025
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Research works printed but not linked: 1
- Straub RE, Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH et al. GAD1, which encodes glutamate decarbozylase 1 (GAD 67), is associated with adult onset schizophrenia in two independent samples. Am J Med Genet 2003; 122B: 177.
Cited by
Items 301–400 of 1,000
Tabarés‐Seisdedos, R., Escámez, T., Giménez, J. A. M., Balanzá‐Martínez, V., Salazar, J., Selva, G., Rubio, C., Vieta, E., Geijo‐Barrientos, E., Martínez‐Arán, A., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.054 · Cited by 59
Global and Temporal Cortical Folding in Patients With Early-Onset Schizophrenia
Penttilä, J., Martinot, M. P., Martinot, J. L., Mangin, J., Burke, L., Corrigall, R. J., Frangou, S., & Cachia, A. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181825aa7 · Cited by 55
Self-citationHayashi‐Takagi, A., & Sawa, A. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.007 · Cited by 55
Systems Biology, Bioinformatics, and Biomarkers in Neuropsychiatry
Alawieh, A. M., Zaraket, F. A., Li, J., Mondello, S., Nokkari, A., Razafsha, M., Fadlallah, B. H., Boustany, R., & Kobeissy, F. H. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00187 · Cited by 57
“The association between neurodevelopmental changes and SZ has been reported in several genomic, transcriptomic, and proteomic studies (Rapoport et al., 2005).”
BackgroundNeuroimaging findings from childhood onset schizophrenia patients and their non-psychotic siblings
Ordóñez, A. E., Luscher, Z. I., & Gogtay, N. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.03.003 · Cited by 57
Ronan, L., Voets, N. L., Hough, M., Mackay, C., Roberts, N., Suckling, J., Bullmore, E., James, A., & Fletcher, P. C. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.034 · Cited by 48
“Although the structural evidence is inconclusive, there is a general consensus that schizophrenia is, at least partly, a disorder of neurodevelopment (Rapoport et al., 2005; Weinberger, 1987).”
BackgroundInfluentialHutchison, A. K., Hunter, S. K., Wagner, B. D., Calvin, E. A., Zerbe, G. O., & Ross, R. G. (2017) · Journal of Attention Disorders · doi:10.1177/1087054713488824 · Cited by 47
Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways
Panaccione, I., Napoletano, F., Forte, A., Kotzalidis, G., Casale, A., Rapinesi, C., Brugnoli, C., Serata, D., Caccia, F., Cuomo, I., et al. (2013) · Current Neuropharmacology · doi:10.2174/1570159x113119990037 · Cited by 47
Prestia, A., Boccardi, M., Galluzzi, S., Cavedo, E., Adorni, A., Soricelli, A., Bonetti, M., Geroldi, C., Giannakopoulos, P., Thompson, P., et al. (2011) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2010.12.015 · Cited by 47
Hadar, R., Bikovski, L., Soto‐Montenegro, M. L., Schimke, J., Maier, P., Ewing, S. G., Voget, M., Wieske, F., Götz, T., Desco, M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.52 · Cited by 50
Neurodevelopmental Origins of Schizophrenia
Weinberger, D. R., & Levitt, P. (2010) · Schizophrenia · doi:10.1002/9781444327298.ch19 · Cited by 49
Xu, L., Dong, W., Zhao, J., & Xu, Y. (2015) · Marine Drugs · doi:10.3390/md13063653 · Cited by 48
Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome
Shashi, V., Kwapil, T. R., Kaczorowski, J. A., Berry, M. N., Santos, C. S., Howard, T. D., Goradia, D. D., Prasad, K. M. R., Vaibhav, D., Rajarethinam, R., et al. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.07.003 · Cited by 53
Kumar, R. A., McGhee, K. A., Leach, S. R., Bonaguro, R. J., Maclean, A. W., Aguirre-Hernández, R., Abrahams, B. S., Coccaro, E. F., Hodgins, S., Turecki, G., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30696 · Cited by 54
“In some patients, neurodevelopmental phenotypes such as altered neurogenesis, reduced dendritic branching, impairment in GABAergic interneurons, ventricular enlargement, or reduced volume of the hippocampus, cerebral cortex, corpus callosum, amygdala, and olfactory bulb have been described [Rapoport et al., 2005; Stra…”
BackgroundThe Role of Caspase-3 Activation in Phencyclidine-Induced Neuronal Death in Postnatal Rats
Wang, C. Z., & Johnson, K. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301202 · Cited by 50
Hennessy, R. J., Baldwin, P. A., Browne, D. J., Kinsella, A., & Waddington, J. L. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.001 · Cited by 56
“In relation to the origins of psychosis, much theorising indicates an important role for early disturbance in brain development (Waddington et al., 1999a; McGrath et al., 2003; Rapoport et al., 2005; van Os and Kapur, 2009).”
Yabut, O., Fernández, G., Huynh, T., Yoon, K., & Pleasure, S. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.031 · Cited by 47
“…have been implicated in a number of neurodevelopmental disorders, such as schizophrenia and autism (Brennand et al., 2012; Hutsler and Zhang, 2010; Rapoport et al., 2005; Smiley et al., 2009; Stoner ibly low levels, whereas Ctip2+ and Tbr1+ cells were readily observed in the P0 s were also…”
Milenkovic, M., Mielnik, C. A., & Ramsey, A. J. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12183 · Cited by 47
Multifaceted genomic risk for brain function in schizophrenia
Chen, J., Calhoun, V. D., Pearlson, G. D., Ehrlich, S., Turner, J. A., Ho, B., Wassink, T. H., Michael, A. M., & Liu, J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.022 · Cited by 47
The Palau Early Psychosis Study: Neurocognitive functioning in high-risk adolescents
Myles‐Worsley, M., Ord, L. M., Ngiralmau, H., Weaver, S. M., Blailes, F., & Faraone, S. V. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.08.003 · Cited by 55
Barnett, J. H., McDougall, F., Xu, M. K., Croudace, T. J., Richards, M., & Jones, P. B. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.102053 · Cited by 45
Sensorimotor gating deficits in “two-hit” models of schizophrenia risk factors
Khan, A., & Powell, S. B. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.10.009 · Cited by 48
Wang, X., Pinto-Duarte, A., Sejnowski, T. J., & Behrens, M. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4907 · Cited by 46
“There is increasing evidence that schizophrenia, with symptoms typically appearing during late adolescence or early adulthood, is a consequence of alterations in early brain development (58, 186).”
Genetics of Childhood-onset Schizophrenia
Asarnow, R. F., & Forsyth, J. K. (2013) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.06.004 · Cited by 48
Epigenetic regulation of fetal brain development and neurocognitive outcome
Petanjek, Z., & Kostović, I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208085109 · Cited by 49
Hippocampal Volume Development in Healthy Siblings of Childhood-Onset Schizophrenia Patients
Mattai, A., Hosanagar, A., Weisinger, B., Greenstein, D., Stidd, R., Clasen, L., Lalonde, F., Rapoport, J., & Gogtay, N. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10050681 · Cited by 45
Self-citationTempelaar, W. M., Termorshuizen, F., MacCabe, J. H., Boks, M. P. M., & Kahn, R. S. (2017) · Psychological Medicine · doi:10.1017/s0033291716002877 · Cited by 45
“(Cannon et al. 2000; Rapoport et al. 2005; Bilder et al. 2006; Kahn & Keefe, 2013).”
Kolář, D., Kletečková, L., Brožka, H., & Valeš, K. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136003 · Cited by 53
Lee, S., Kim, K. R., Lee, S. Y., & An, S. K. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.5.539 · Cited by 48
Fractal Dimension Analysis of Subcortical Gray Matter Structures in Schizophrenia
Zhao, G., Denisova, K., Sehatpour, P., Long, J., Gui, W., Qiao, J., Javitt, D. C., & Wang, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155415 · Cited by 51
Larimore, J. L., Ryder, P. V., Kim, K., Ambrose, L. A., Chapleau, C. A., Calfa, G. D., Groß, C., Bassell, G. J., Pozzo‐Miller, L. D., Smith, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065069 · Cited by 46
Arnold, J. C., Boucher, A. A., & Karl, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884726 · Cited by 53
Lennertz, L., Wagner, M., Wölwer, W., Schuhmacher, A., Frommann, I., Berning, J., Schulze‐Rauschenbach, S., Landsberg, M. W., Steinbrecher, A., Alexander, M., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0233-3 · Cited by 47
Modeling neurodevelopmental cognitive deficits in tasks with cross‐species translational validity
Cope, Z. A., Powell, S. B., & Young, J. W. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12268 · Cited by 48
“This loss is associated with many mixed reports of impairments in vigilance and attention in humans (Reiss & Hall 2007).”
BackgroundPolymorphisms in MICB are associated with human herpes virus seropositivity and schizophrenia risk
Shirts, B. H., Kim, J. J., Reich, S. S., Dickerson, F., Yolken, R. H., Devlin, B., & Nimgaonkar, V. L. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.021 · Cited by 45
The molecular pathology of schizophrenia—Focus on histone and DNA modifications
Akbarian, S. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.018 · Cited by 43
Wędzony, K., Fijał, K., Maćkowiak, M., Chocyk, A., & Zajaczkowski, W. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.016 · Cited by 49
Progranulin (GRN)in two siblings of a Latino family and in other patients with Schizophrenia
Momeni, P., DeTucci, K., Straub, R. E., Weinberger, D. R., Davies, P., Grafman, J., Hardy, J., & Huey, E. D. (2010) · Neurocase · doi:10.1080/13554790903456209 · Cited by 45
Magri, C., Gardella, R., Barlati, S., Podavini, D., Iatropoulos, P., Bonomi, S., Valsecchi, P., Sacchetti, E., & Barlati, S. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30294 · Cited by 52
Scherr, M., Hamann, M., Schwerthöffer, D., Froböse, T., Vukovich, R., Pitschel‐Walz, G., & Bäuml, J. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.605171 · Cited by 48
Millan, M. J., & Brocco, M. (2008) · Therapies · doi:10.2515/therapie:2008041 · Cited by 47
Defective neurogenesis and schizophrenia-like behavior in PARP-1-deficient mice
Hong, S., Yi, J. H., Lee, S., Park, C., Ryu, J. H., Shin, K. S., & Kang, S. J. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2174-0 · Cited by 48
Magri, C., Gardella, R., Valsecchi, P., Barlati, S. D., Guizzetti, L., Imperadori, L., Bonvicini, C., Tura, G. B., Gennarelli, M., Sacchetti, E., et al. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30674 · Cited by 46
“CNS plasticity and/or development [Rapoport et al., 2005].”
BackgroundInfluentialComplement C4B protein in schizophrenia
Mayilyan, K. R., Dodds, A. W., Boyajyan, A. S., Soghoyan, A. F., & Sim, R. B. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227803 · Cited by 49
“It is now thought that abnormal development in a compromised prenatal and/or early postnatal environment may be a risk factor for schizophrenia, which manifests after puberty (Marenco and Weinberger 2000; Rapoport et al. 2005).”
BackgroundKrug, I., Taborelli, E., Sallis, H., Treasure, J., & Micali, N. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.11.003 · Cited by 41
“Numerous studies [15] have shown that OCs can translate into lasting alterations in the nervous system and the brain, which in turn can increase the risk for schizophrenia: this is what has become known as the ‘neurodevelopmental theory of schizophrenia’ [16,17].”
BackgroundAltered serine/threonine kinase activity in schizophrenia
McGuire, J. L., Hammond, J. H., Yates, S. D., Chen, D., Haroutunian, V. H., Meador‐Woodruff, J. H., & McCullumsmith, R. E. (2014) · Brain Research · doi:10.1016/j.brainres.2014.04.029 · Cited by 46
“…exposure to pathogens and subsequent neuroinflammation (Bronson et al., 2011; Hahn et al., 2006; Vorhees et al., 2012), and developmental miscues resulting in defects in the wiring of neuronal circuits (Hoftman et al., 2013; Lewis et al., 1999; Marenco and Weinberger, 2000; Rapoport et al., 2005).”
BackgroundDISC1 as a therapeutic target for mental illnesses
Hikida, T., Gamo, N. J., & Sawa, A. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.719879 · Cited by 44
“3 Developmental trajectory: a possible template to develop preventive medications? Although drug-induced models of mental illnesses, such as those with phencyclidine (PCP) in adulthood [108,109], are useful as templates for drug discovery, these models may not reflect an important pathological feature of major mental…”
Wadehra, S., Pruitt, P. J., Murphy, E. R., & Diwadkar, V. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.010 · Cited by 44
Lee, S. J., Kim, K. R., Lee, S. Y., & An, S. K. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.2.186 · Cited by 45
Willette, A. A., Coe, C. L., Colman, R. J., Bendlin, B. B., Kastman, E. K., Field, A. S., Alexander, A. L., Allison, D. B., Weindruch, R. H., & Johnson, S. C. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.10.006 · Cited by 41
Nagai, T., Kitahara, Y., Shiraki, A., Hikita, T., Taya, S., Kaibuchi, K., & Yamada, K. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.071 · Cited by 41
Addington, A. M., & Rapoport, J. L. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02478.x · Cited by 44
Self-citationPharmacological enrichment of polygenic risk for precision medicine in complex disorders
Reay, W. R., Atkins, J., Carr, V. J., Green, M. J., & Cairns, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-57795-0 · Cited by 42
Altered immune function in unaffected first-degree biological relatives of schizophrenia patients
Martínez‐Gras, I., García-Sánchez, F., Guaza, C., Rodríguez–Jiménez, R., Andres, E. M., Palomo, T., Rubio, G., & Borrell, J. I. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.05.036 · Cited by 46
Cannabis and psychosis: Have we found the missing links?
Parakh, P., & Basu, D. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.03.012 · Cited by 49
“One view of schizophrenia is that it is a neurodevelopmental disorder (Rapoport et al., 2005; Weinberger, 1996).”
BackgroundWhite Matter Injuries Induced by MK‐801 in a Mouse Model of Schizophrenia Based on NMDA Antagonism
Xiu, Y., Kong, X., Zhang, L., Qiu, X., Chao, F., Peng, C., Gao, Y., Huang, C., Wang, S., & Tang, Y. C. (2014) · The Anatomical Record · doi:10.1002/ar.22942 · Cited by 43
“Previous investigations into the etiology of SZ have focused on genetic factors and environmental insults (Rapoport et al., 2005; Nagai et al., 2011), neuronal atrophy (Glantz et al., 2006), neuronal apoptosis (Ahn et al., 2009), alterations in neuronal density (Elberger and Deng, 2003; Yang et…”
BackgroundSignes neurologiques mineurs et schizophrénie : revue des données actuelles
Krebs, M., & Mouchet-Mages, S. (2007) · Revue Neurologique · doi:10.1016/s0035-3787(07)78400-x · Cited by 47
Development and validation of a brain maturation index using longitudinal neuroanatomical scans
Cao, B., Mwangi, B., Hasan, K. M., Selvaraj, S., Zeni, C., Zunta‐Soares, G. B., & Soares, J. C. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.05.071 · Cited by 42
Kirschner, M., Schmidt, A., Hodzic-Santor, B. H., Burrer, A., Manoliu, A., Zeighami, Y., Yau, Y. H. C., Abbasi, N., Maatz, A., Habermeyer, B., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa169 · Cited by 44
Dynamics of Subcellular Proteomes During Brain Development
McClatchy, D. B., Liao, L., Lee, J. H., Park, S. K., & Yates, J. R. (2012) · Journal of Proteome Research · doi:10.1021/pr201176v · Cited by 40
The Link Between Perinatal Glucocorticoids Exposure and Psychiatric Disorders
Huang, L. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318212c29b · Cited by 47
Deng, Y., Hung, K. S. Y., Lui, S. S. Y., Chui, W. W. H., Lee, J. C. W., Wang, Y., Li, Z., Mak, H. K. F., Sham, P. C., Chan, R. C. K., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.010 · Cited by 40
Rethinking mental disorders: The role of learning and brain plasticity
Morris, S. E., Rumsey, J. M., & Cuthbert, B. N. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139015 · Cited by 35
“For decades, accumulating evidence has supported neurodevelopmental and genetic contributions to many mental disorders, including schizophrenia, depression and bipolar disorder (Ishizuka et al., 2006; Rapoport et al., 2005; Stevens et al., 2010; Weinberger, 1987).”
Generation and Characterization of Conditional Heparin-Binding EGF-Like Growth Factor Knockout Mice
Oyagi, A., Oida, Y., Kakefuda, K., Shimazawa, M., Shioda, N., Moriguchi, S., Kitaichi, K., Nanba, D., Yamaguchi, K., Furuta, Y., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007461 · Cited by 43
Prevention of schizophrenia deficits via non-invasive adolescent frontal cortex stimulation in rats
Hadar, R., Winter, R. E., Edemann-Callesen, H., Wieske, F., Habelt, B., Khadka, N., Felgel-Farnholz, V., Hlusicka, E. B., Reis, J., Tătărău, C. A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0356-x · Cited by 43
Behavioral Animal Models of Antipsychotic Drug Actions
Peleg‐Raibstein, D., Feldon, J., & Meyer, U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_14 · Cited by 41
Li, D., & He, L. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201680 · Cited by 44
Bender, S., Weisbrod, M., & Resch, F. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0742-4 · Cited by 44
“Expression studies found a reduced number of GAD 67-expriming interneurons in the anterior cingulate (Woo et al., 2004) and the dorsolat- eral prefrontal cortex (DLPFC) of schizophrenic patients (Kalkman and Loetscher, 2003; Rapoport et al., 2005).”
BackgroundPlaze, M., Mangin, J., Martinot, M. P., Artiges, É., Olié, J., Krebs, M., Gaillard, R., Martinot, J. L., & Cachia, A. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.10.011 · Cited by 39
Associating schizophrenia, long non-coding RNAs and neurostructural dynamics
Merelo, V., Durand, D., Lescallette, A. R., Vrana, K. E., Hong, L. E., Faghihi, M. A., & Bellon, A. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00057 · Cited by 39
Dacquino, C., Rossi, P. D., & Spalletta, G. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.02.029 · Cited by 43
Matricon, J., Bellon, A., Frieling, H., Kébir, O., Pen, G. L., Beuvon, F., Daumas‐Duport, C., Jay, T. M., & Krebs, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010291 · Cited by 45
Torri, F., Akelai, A., Lupoli, S., Sironi, M., Amann‐Zalcenstein, D., Fumagalli, M., Fiume, C. D., Ben‐Asher, E., Kanyas, K., Cagliani, R., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-152611 · Cited by 41
Li, J.-T., Zhao, Y., Wang, H.-L., Wang, X.-D., Su, Y., & Si, T. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.003 · Cited by 43
Karl, T. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00106 · Cited by 42
Li, M., Becker, B., Zheng, J., Zhang, Y., Chen, H., Liao, W., Duan, X., Liu, H., Zhao, J., & Chen, H. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby063 · Cited by 38
Takahashi, K., Nakagawasai, O., Sakuma, W., Nemoto, W., Odaira, T., Lin, J.-R., Onogi, H., Srivastava, L. K., & Tan–No, K. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.034 · Cited by 38
Chandrashekar, P. B., Alatkar, S., Wang, J., Hoffman, G. E., He, C., Jin, T., Khullar, S., Bendl, J., Fullard, J. F., Roussos, P., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01248-6 · Cited by 37
Shirts, B. H., Wood, J. A., Yolken, R. H., & Nimgaonkar, V. L. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30603 · Cited by 37
“Interactions ofmultiple genes and environmental factors have been invoked among the reasons for observed inconsistencies in studies that investigated genetic or environmental risk in isolation [Petronis, 2004; Rapoport et al., 2005].”
BackgroundVenerosi, A., Cutuli, D., Chiarotti, F., & Calamandrei, G. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.10.010 · Cited by 45
Haukvik, U. K., Saetre, P., McNeil, T. F., Bjerkan, P. S., Andreassen, O. A., Werge, T. M., Jönsson, E. G., & Agartz, I. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.001 · Cited by 43
“Foetal hypoxia may cause damage to the developing brain (Verdoux and Sutter, 2002) and increase the susceptibility for later development of schizophrenia (Marenco and Weinberger, 2000; Rapoport et al., 2005).”
Alaerts, M., Ceulemans, S., Forero, D., Moens, L. N., De Zutter, S., Heyrman, L., Lenaerts, A.-S., Norrback, K.-F., De Rijk, P., Nilsson, L.-G., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.82 · Cited by 37
Li, D., & He, L. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.017 · Cited by 37
A Sensitive Period for GABAergic Interneurons in the Dentate Gyrus in Modulating Sensorimotor Gating
Guo, N., Yoshizaki, K., Kimura, R., Suto, F., Yanagawa, Y., & Osumi, N. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0032-12.2013 · Cited by 39
“In general, neuropsychiatric diseases, such as schizophrenia, are thought to result from a developmental defect with poorly defined etiology and pathophysiology (Weinberger, 1996; Lewis and Levitt, 2002; Rapoport et al., 2005).”
BackgroundTelomere length and human hippocampal neurogenesis
Palmos, A., Duarte, R. R. R., Smeeth, D. M., Hedges, E. C., Nixon, D. F., Thuret, S., & Powell, T. R. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00863-w · Cited by 38
“(vi) Telomere shortening may not occur during early neurodevelopment Previous evidence suggests that telomere shortening and reduced rates of hippocampal neurogenesis are specific to the adult brain [42–44], but schizophrenia risk and cognitive function are also known to be affected by prenatal neurodevelopmental fact…”
BackgroundAstrocytic cell adhesion genes linked to schizophrenia correlate with synaptic programs in neurons
Pietiläinen, O. P. H., Trehan, A., Meyer, D., Mitchell, J. M., Tegtmeyer, M., Valakh, V., Gebre, H., Chen, T., Vartiainen, E., Farhi, S. L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2022.111988 · Cited by 39
Wilson, C., & Terry, A. V. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.015 · Cited by 39
Curtis, D., Sood, A., Phillips, T. J., Leinster, V. H. L., Nishiguchi, A., Coyle, C. S., Lacharme‐Lora, L., Beaumont, O., Kemp, H., Goodall, R., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.003 · Cited by 37
Reinwald, J., Becker, R., Mallien, A. S., Falfán-Melgoza, C., Sack, M., von Hohenberg, C. C., Braun, U., Cosa‐Linan, A., Gass, N., Vasilescu, A.-N., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.12.010 · Cited by 41
Gagné, A.-M., Hébert, M., & Maziade, M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.04.007 · Cited by 35
No evidence for structural brain changes in young adolescents at ultra high risk for psychosis
Ziermans, T. B., Durston, S., Sprong, M., Nederveen, H., van Haren, N. E. M., Schnack, H. G., Lahuis, B., Schothorst, P. F., & van Engeland, H. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.013 · Cited by 38
Control of cortex development by ULK4, a rare risk gene for mental disorders including schizophrenia
Lang, B., Zhang, L., Jiang, G., Hu, L., Lan, W., Zhao, L., Hunter, I., Pruski, M., Song, N., Huang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep31126 · Cited by 36
Schultze‐Lutter, F., Ruhrmann, S., Michel, C., Kindler, J., SCHIMMELMANN, B. G., & Schmidt, S. J. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0949-4 · Cited by 37
Challenges and opportunities for the development of new antipsychotic drugs
Forray, C., & Buller, R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.05.009 · Cited by 40
Accelerated Aging of Functional Brain Networks Supporting Cognitive Function in Psychotic Disorders
Sheffield, J. M., Rogers, B. P., Blackford, J. U., Heckers, S., & Woodward, N. D. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.016 · Cited by 36
Saleem, A., Qurat-ul-Ain, Q.-U.-A., & Akhtar, M. F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.895668 · Cited by 35
Altered asymmetry of the anterior cingulate cortex in subjects at genetic high risk for psychosis
Park, H. Y., Hwang, J. Y., Jung, W. H., Shin, N. Y., Shim, G., Jang, J. H., & Kwon, J. S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.027 · Cited by 34
Spellmann, I., Müller, N., Musil, R., Zill, P., Douhet, A., Dehning, S., Cerovecki, A., Bondy, B., Möller, H., & Riedel, M. J. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0800-9 · Cited by 34
Perinatal kynurenine 3‐hydroxylase inhibition in rodents: Pathophysiological implications
Ceresoli‐Borroni, G., Guidetti, P., Amori, L., Pellicciari, R., & Schwarcz, R. M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21183 · Cited by 35
“This could be especially detrimental in individuals with a genetic vulnerability for brain diseases such as schizophrenia and substance abuse, which have been linked to such early neurochemical impairments (Palomo et al., 2004; Rapoport et al., 2005).”
BackgroundSphingolipid abnormalities in psychiatric disorders: a missing link in pathology?
Narayan, S., & Thomas, E. A. (2010) · Frontiers in bioscience · doi:10.2741/3822 · Cited by 38
“CNS development The neurodevelopmental model of schizophrenia posits that abnormalities during critical developmental periods increase the risk for the subsequent emergence of clinical symptoms (52, 53).”
BackgroundResult
Metadata
- Authors
- Rapoport, J. L., Addington, A. M., Frangou, S., & Psych, M. R. C.
- Affiliations
- National Institutes of Health (US)
- King's College London (GB)
- Corresponding author
- Rapoport, J L
- Venue
- Molecular Psychiatry
- Published
- 2005-02-08
- Volume
- 10
- Issue
- 5
- Pages
- 434-449
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2009995715
- Cited by
- 993
- References
- 180
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 16 · 2022: 31 · 2021: 21 · 2020: 31 · 2019: 40 · 2018: 29 · 2017: 46 · 2016: 36 · 2015: 61 · 2014: 69 · 2013: 72 · 2012: 89
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Update notices
- erratum (2005-05-26)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- schizophrenia, neurodevelopmental model, gray matter loss, early-onset schizophrenia, schizophrenia risk genes, 22q11.2 deletion syndrome, dysbindin, prenatal infection, gene-environment interaction, brain development, age of onset, heritability
- MeSH terms
- Adult, Brain, Child, Female, Humans, Infant, Models, Neurological, Models, Psychological, Pregnancy, Pregnancy Complications, Prenatal Exposure Delayed Effects, Risk Factors, Schizophrenia, Schizophrenic Psychology, Gene Expression Regulation, Developmental, Genetic Predisposition to Disease, Preconception Injuries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.